Literature DB >> 2695500

[Use of the TDF factor in soft roentgen radiotherapy].

M Landthaler1, O Braun-Falco.   

Abstract

In a prospective randomized study 164 patients with altogether 142 basal cell carcinomas and 24 squamous cell carcinomas were each irradiated with a single dose of 3 Gy daily on 20 consecutive days, giving a total dose of 60 Gy (TDF factor 123). In another group of 155 patients, with altogether 148 basal cell carcinomas and 20 squamous cell carcinomas, each patient received 4 Gy 3 times per week until 12 irradiations had been administered, giving a total dose of 48 Gy (TDF factor 103). The cure rates in patients with basal cell carcinomas did not differ between the two groups: 90% were cured by the higher total dose and 92%, by the lower dose. The high dose regimen brought about a cure in 96% of squamous cell carcinomas, in contrast to only 85% with the low dose regimen. Owing to the small number of patients the difference was not statistically significant. These data demonstrate that basal cell carcinomas can be controlled by low-dose irradiation regimens. Squamous cell carcinomas may have a lower radiosensitivity than basal cell carcinomas and may require higher doses.

Entities:  

Mesh:

Year:  1989        PMID: 2695500

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  3 in total

1.  Outcomes of radiation therapy for advanced T3/T4 nonmelanoma cutaneous squamous cell and basal cell carcinoma.

Authors:  S K Kim; C A Barker
Journal:  Br J Dermatol       Date:  2017-12-06       Impact factor: 9.302

2.  Interventions for basal cell carcinoma of the skin.

Authors:  Jason Thomson; Sarah Hogan; Jo Leonardi-Bee; Hywel C Williams; Fiona J Bath-Hextall
Journal:  Cochrane Database Syst Rev       Date:  2020-11-17

3.  SKIN-COBRA (Consortium for Brachytherapy data Analysis) ontology: The first step towards interdisciplinary standardized data collection for personalized oncology in skin cancer.

Authors:  Valentina Lancellotta; Josè Luis Guinot; Bruno Fionda; Agata Rembielak; Alessandro Di Stefani; Stefano Gentileschi; Francesco Federico; Ernesto Rossi; Benjamin Guix; Artur Jan Chyrek; Arenas Meritxell; Silvia Rodriguez Villalba; Giuseppe Ferdinando Colloca; Nicola Dinapoli; Carlotta Masciocchi; Jacopo Lenkowicz; Nicola Dino Capocchiano; Andrea Damiani; Vincenzo Valentini; Gyorgy Kovács; Luca Tagliaferri
Journal:  J Contemp Brachytherapy       Date:  2020-04-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.